Lead Exposure and Prevention Advisory Committee (LEPAC) Charter Renewal
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services (HHS), has announced the formal renewal of the charter governing the Lead Exposure and Prevention Advisory Committee (LEPAC). This renewal ensures the committee retains its legal standing and operational authority to continue advising the CDC on matters related to lead exposure risks and prevention strategies in the United States. LEPAC serves as a federal advisory body responsible for providing expert guidance on public health policies and programs aimed at reducing lead exposure, particularly among vulnerable populations such as children. The committee's recommendations inform federal initiatives related to blood lead level monitoring, environmental remediation, and community health interventions. The charter renewal is an administrative requirement under the Federal Advisory Committee Act (FACA), which mandates periodic reauthorization of federal advisory committees to confirm their continued necessity and relevance. This renewal does not alter the committee's existing mandate or composition but reaffirms its ongoing role in shaping CDC's lead prevention policies.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- CDC formally renews the LEPAC charter as of the notice date (March 27, 2026), maintaining the committee's legal authority
- Renewal is mandated under the Federal Advisory Committee Act (FACA), which requires periodic reauthorization of all federal advisory committees
- No changes to LEPAC's existing mandate, membership structure, or scope of advisory responsibilities
+ 2 more changes with Pro
Obligations
What this law requires
CDC must maintain LEPAC's charter renewal documentation and ensure the committee retains legal standing and operational authority under the Federal Advisory Committee Act (FACA)
LEPAC must provide expert guidance and recommendations to the CDC on public health policies and programs aimed at reducing lead exposure
LEPAC must advise the CDC on matters related to blood lead level monitoring strategies and initiatives
LEPAC must provide recommendations on environmental remediation policies and programs to reduce lead exposure
LEPAC must advise on community health interventions targeting vulnerable populations, particularly children, regarding lead exposure prevention